Treatment with glitazones, peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists, was shown not only to improve insulin resistance and glycemic control, but also to decrease arterial stiffness in patients with type 2 diabetes mellitus [64, 100, 101]. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.